Quantify the Narrative
LucidAlpha turns a stream of biotech and pharmaceutical events into a quantitative, chartable signal. Like a stock price chart, but for drug development and brand trajectory. Designed for competitive intelligence, portfolio monitoring, and investment analysis.
The Engine Behind the Signal
How LucidAlpha transforms qualitative events into quantitative intelligence.
The Composite Score
A score from 0 to 100 representing the aggregate “confidence” of a drug candidate. It uses a momentum-preserving model: events deliver an immediate impulse that decays naturally over a category-specific half-life.
Sentiment Scoring
Measures directional impact (-1.0 to +1.0). An FDA approval might be +0.95, while a minor enrollment delay is -0.1. It answers: “How does this event affect the probability of commercial success?”
Confidence Weighting
Acts as a multiplier (0.0 to 1.0) based on data reliability. Official FDA records score near 1.0, while unverified rumors score low, allowing speculative events to be tracked without distorting the chart.
8 Dimensions of Analysis
Every data point is categorized. LucidAlpha automatically adjusts category weights based on the drug’s development stage (Preclinical through Mature).
Clinical Trial
Phase transitions, endpoint results, dose-escalation data.
Regulatory
IND/NDA filings, PDUFA dates, approvals, AdCom votes.
Patent / IP
Grants, challenges, Orange Book listings, exclusivity.
Publication
Peer-reviewed papers, conference presentations, posters.
News / Market
Partnerships, M&A, analyst ratings, executive changes.
Manufacturing
GMP validation, scale-up milestones, supply chain.
Commercial
Pricing, payer coverage, formulary placements, TRx data.
Safety / PV
Adverse events, FDA communications, boxed warnings.
Advanced Analytical Tools.
Beyond the basic chart.
Apply standard technical analysis to fundamental events, correlate with public interest, and model future scenarios.
Technical Analysis & Sub-Indices
Apply SMA, EMA, MACD, and RSI to the composite score. Break down the signal into 5 sub-indices like Development Momentum vs. Risk Burden.
Google Trends Correlation
Overlay search interest data to identify divergences. Spot “Insider-driven” momentum or “Hype risk” when public awareness disconnects from fundamentals.
Scenario Modelling
Add hypothetical future events (e.g., Phase 3 success vs. failure) to project score trajectories and assess asymmetric risk/reward.
Event Clustering Heatmap
Visualize event density and sentiment across categories over time to spot sustained activity or hidden warning signs.
Part of a connected intelligence toolkit
LucidAlpha is built by LucidQuest. Pair it with sister tools that capture field insight, track search demand and test how competitors could respond.
Biopharma intelligence, primary research, competitive strategy and investment decision support. The analysts and methodology behind LucidAlpha.
NexusBrain
Captures what your teams see in the field about markets and competitors, and turns it into structured intelligence for people and AI tools.
Explore NexusBrainLucidScope
How AI systems describe your therapies, brands and competitors, as a platform or an AI answer audit.
Explore LucidScopeLucidTrends
Search-trend intelligence for biopharma and healthcare: what the market is searching for, across countries and over time.
Explore LucidTrendsLucidSearch
A search engine dedicated to biopharma, with analyst views, clinical, patent and podcast results in one place.
Explore LucidSearchQuickAnswers
Rapid primary research with KOLs, physicians, payers and other market stakeholders, on a decision timeline.
Explore QuickAnswersLucidWargames
AI-enabled competitive simulation and scenario-based strategy testing, as a self-serve platform or a facilitated workshop.
Explore LucidWargamesLucidCGT
Specialist strategy and intelligence for cell, gene and RNA therapies.
Explore LucidCGTSearch signals, in depth. LucidAlpha overlays Google Trends on every score; LucidTrends goes further, with multi-country heatmaps, related-query analysis and trend forecasting.
See the signal through the noise.
Stop relying on scattered news feeds. Start tracking your competitors’ true trajectory with LucidAlpha.
Tell us what you want to track.
Book a demo on your own competitor set, ask about plans, or explore a custom portfolio-monitoring project.